Kanta Loha Tablet as a Madhumeha hara drug – A single case study

Authors

  • Bineesh E P PhD Scholar, ITRA
  • Prashant Bedarkar
  • Patgiri B J
  • Mandip Goyal

DOI:

https://doi.org/10.47552/ijam.v12i3.1872

Keywords:

Rasa Shastra, Kanta Loha Bhasma, Magnetite, Anti-hyperglycaemic effect

Abstract

Rasa Shastra which explains a compendium of formulations that act as spectacular remedies for numerous diseases. Metals were used for Deha Vada (for the cure of ailments) and also for Rasayana Karma(Immunity boosting). Loha Bhasma had been using in many formulations from ancient time itself. Kanta Loha, which is superior among Loha can be considered as Magnetite. The Magnetite should contain more than 60% of iron content in it. The incineration process  done according to the reference of classical Rasa Shastra classics. The controversy term “iron overload lead to diabetes” needs to be rechecked by monitoring the results of tests in diabetic patients after medication in the form of Kanta Loha Bhasma. In this article a single case study result showing towards the anti diabetic effect in human subject.

Author Biographies

Bineesh E P, PhD Scholar, ITRA

PhD Scholar, Rasa Shastra and Bhaishajya Kalpana Department, ITRA, Jamnagar. Gujarat.

Prashant Bedarkar

Associate Professor, Rasa Shastra and Bhaishajya Kalpana Department, ITRA, Jamnagar. Gujarat

Patgiri B J

Professor and Head, Rasa Shastra and Bhaishajya Kalpana Department, ITRA, Jamnagar. Gujarat

Mandip Goyal

Associate professor, Department of Kaya Chikitsa, ITRA, Jamnagar. Gujarat.

Downloads

Published

17-06-2021

How to Cite

E P, B., Bedarkar, P., J, P. B., & Goyal, M. (2021). Kanta Loha Tablet as a Madhumeha hara drug – A single case study. International Journal of Ayurvedic Medicine, 12(2), 386–390. https://doi.org/10.47552/ijam.v12i3.1872

Issue

Vol. 12 No. 2 (2021): April - June 2021

Section

Case Reports

License

The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.

This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.

The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

https://creativecommons.org/licenses/by-nc-sa/4.0/